Merck & Co., Inc. (NYSE:MRK)

Stock Price: $105.68
+1.65 (1.59%)
Updated Feb 7, 2023 09:03 PM GMT+0000
Featured app
eToro
Invest now
<p>79% of retail CFD accounts lose money</p>
Overview
Financials
Statistics
Profile
Chart
Market Cap 267.94B
Revenue 57.52B
Gross Profit 40.59B
Shares Out 2.54B
EPS (ttm) 6.08
PE Ratio 17.5584
Forward PE 13.9901
Dividend Rate (ttm) 2.7699
Dividend Yield 0.0262
Trading Day Feb 7
Last Price $105.68
Previous Close $104.03
Change ($) 1.65
Change (%) 1.59%
Day's Open 103.66
Day's Range 103.56 - 105.93
Day's Volume 6.64M
52 Week Range 70.61 - 115.49

About Merck & Co., Inc.

For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.

News

Quick info

Country
United States
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
68,000
CEO
Kenneth Frazier
Address
2000 Galloping Hill Rd
Kenilworth
New Jersey
07033-1310
Phone
19087404000
Website
www.merck.com
Ticker Symbol
MRK
Reporting Currency
USD